Pharmaceuticals

India has emerged as the pharmacy to the world - a point illustrated during the pandemic and driven by scale economics and export prowess.

There's robust potential in US tech, pharma and Qantas, while red flags exist in a number of ASX companies that make them short candidates.

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

The Pharma & Biotech market had a relatively positive month with 41.5% of the coverage universe posting positive share price movements for the month of September. Over...

In this wire, we take a look at five ASX-listed pharma & biotech companies whose share prices rallied in July.

In this episode, Nina shares her background and what it taught her about the challenge of running a biotech firm.

The growth of this specialised biopharmaceutical field has coincided with increased attention from the large global pharma companies

There were three companies in the Pharma & Biotech sector whose share prices rallied 70%+ in June, although share price increases for the sector were relatively muted...

Global healthcare awareness is on the rise. However, the winners in this segment may not be in traditional areas!

There were some strong moves in the Pharma and Biotech sector in May, with the share prices of 33 companies in the coverage universe rising by 10% or more. Below we...

Markets were more subdued in April after the strong start to the year. The S&P/ASX 200 Accumulation Index was down 2.9% and the S&P/ASX Small Ordinaries Accumulation...

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

The Pharma and Biotech market was relatively buoyant in March with 49% of share prices in the coverage universe increasing for the month. There was some...

Below, we take a look at four stocks that have been amongst the best performers in the first two months of the new year.

There was some significant news flow in November 2023 which saw the shares of a number of pharma and biotech companies rally strongly. The share price of three...

We weigh the latest blockbuster weight-loss drugs against pharmaceuticals (and others) that have gone before

Breakthroughs in obesity drugs look extraordinarily profitable for 2 stocks. But, with improvements, a raft of sectors might be affected.

It was a tough month for the Pharma & Biotech coverage universe with 73.2% of share prices for companies in the universe either flat or negative for the month of...

In this edition of the Movers & Shakers for Pharma & Biotech, we highlight 5 stocks that were on the move in September. Biotron Limited (ASX: BIT) Bitron shares were...

With usage of anti-obesogenic drugs on the rise, the end of obesity comes winners and losers. And investment opportunties